Testing effectiveness (Phase 2)Study completedNCT02383498What this trial is testingQUILT-3.011 Phase 2 Yeast-Brachyury Vaccine ChordomaWho this might be right forChordoma NantCell, Inc. 24
Testing effectiveness (Phase 2)UnknownNCT00839111What this trial is testingSorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin TreatmentWho this might be right forColorectal Neoplasms Fudan University 43
Testing effectiveness (Phase 2)UnknownNCT04664244What this trial is testingCombination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous CarcinomaWho this might be right forRecurrent Cervical CarcinomaRadiotherapyEpidermal Growth Factor Receptor+4 more Lei Li 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT05132166What this trial is testingPhase II Study to Compare the Potential Long-Lasting Positive Effect of Decidual Stromal Cells to the Best Available Treatment in Graft Versus Host DiseaseWho this might be right forGraft Vs Host Disease University Health Network, Toronto 50
Early research (Phase 1)Looking for participantsNCT07238075What this trial is testingADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic CancersWho this might be right forAdvanced MalignancyAdvanced Solid CancersMetastatic Solid Tumors Adcytherix SAS 290
Testing effectiveness (Phase 2)Ended earlyNCT04896658What this trial is testingBelantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple MyelomaWho this might be right forRelapsed/Refractory Multiple Myeloma University of Maryland, Baltimore 10
Testing effectiveness (Phase 2)UnknownNCT01192230What this trial is testingStudy of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer PatientsWho this might be right forCarcinoma, Non-Small-Cell Lung Fudan University 30
Testing effectiveness (Phase 2)WithdrawnNCT02014831What this trial is testingEfficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)Who this might be right forSquamous Cell Carcinoma of the Penis Centre Leon Berard
Testing effectiveness (Phase 2)UnknownNCT00892827What this trial is testingCombined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic LeukemiaWho this might be right forAdvanced Refractory Chronic Lymphocytic Leukemia Wolfson Medical Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT07090525What this trial is testingBevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous EffusionsWho this might be right forOverall Response Rate Qingdao Central Hospital 60
Not applicableUnknownNCT03910140What this trial is testingTILA-TACE in Treatment of Hepatocellular CarcinomaWho this might be right forTumor Response RateOverall Survival Second Affiliated Hospital, School of Medicine, Zhejiang University 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT05114746What this trial is testingStudy of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in JapanWho this might be right forProstate Cancer Novartis Pharmaceuticals 110
Not applicableLooking for participantsNCT05749627What this trial is testingUsing Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid TumorsWho this might be right forAdvanced Malignant Solid Tumors The First Affiliated Hospital of Nanchang University 20
Not applicableStudy completedNCT02603315What this trial is testingVascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)Who this might be right forMalignant Pleural Mesotheliomas Ain Shams University 50
Testing effectiveness (Phase 2)UnknownNCT04899427What this trial is testingPhase II Study of Orelabrutinib Combined With PD-1 Inhibitor in Relapsed/Refractory Primary Central Nervous System LymphomaWho this might be right forPrimary Central Nervous System Lymphoma Peking Union Medical College Hospital 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT05670106What this trial is testingEvaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPCWho this might be right forMetastatic Castration-Resistant Prostate Cancer (mCRPC) Novartis Pharmaceuticals 62
Not applicableUnknownNCT03336554What this trial is testingEpigenetic Biomarker for OsteosarcomaWho this might be right forHistologic Response (Tumor Necrosis Rate)Objective Response Rate for Neoadjuvant Chemotherapy, ORRProgression-free Survival, PFS+1 more Peking University People's Hospital 100
Not applicableStudy completedNCT01291667What this trial is testingStudy for HER2-Overexpressed MBC Patients Treated by Cipterbin® Plus vinorelbinEWho this might be right forProgress-free SurvivalOverall Response RateAdverse Events Shanghai CP Guojian Pharmaceutical Co., Ltd. 330
Not applicableStudy completedNCT04902560What this trial is testingResponse Rate to Ceftriaxone 1g IM in Gonorrhoea : a French Retrospective Monocentric StudyWho this might be right forGonorrhea University Hospital, Montpellier 120
Testing effectiveness (Phase 2)Ended earlyNCT01466868What this trial is testingStudy of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell LymphomaWho this might be right forDiffuse Large B Cell Lymphoma Centre Leon Berard 22